Ionis Pharmaceuticals Inc (NAS:IONS)
$ 38.3 -0.5 (-1.29%) Market Cap: 5.59 Bil Enterprise Value: 4.90 Bil PE Ratio: 0 PB Ratio: 18.87 GF Score: 70/100

Ionis Pharmaceuticals Inc at Bank of America Merrill Lynch Healthcare Conference (Virtual) Transcript

May 13, 2020 / 05:40PM GMT
Release Date Price: $54.43 (-2.63%)
Jason Matthew Gerberry
BofA Merrill Lynch, Research Division - MD in US Equity Research

Good day, everybody, and thank you so much for joining us at the Annual Bank of America Health Care Conference. My name is Jason Gerberry. I am the specialty pharma and smid-cap biotech analyst at Bank of America. I'm pleased to be introducing our next company presenter, Ionis Pharmaceuticals. Pleased to be joined by CEO, Brett Monia; and CFO, Beth Hougen. So first of all, Beth and Brett, thank you for joining us at the conference.

Brett P. Monia
Ionis Pharmaceuticals, Inc. - Founder, CEO & Director

Thanks, Jason. Pleasure to be here. Thanks for the invitation.

Jason Matthew Gerberry
BofA Merrill Lynch, Research Division - MD in US Equity Research

Of course, of course. So look, I've got a number of questions, and obviously, those who are dialed in or can send questions to me electronically as well. But I figured we'd go through some of the more interesting pipeline programs and value drivers in the model. And from our

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot